Drrx stock forecast.

On June 7, 2023, DURECT Corporation announced the successful completion of enrollment for Phase 2b AHFIRM clinical trial. The trialGet the latest Dare Bioscience Inc (DARE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.The forecasts range from a low of $32.32 to a high of $38.85. ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K ... The firm increased its portfolio allocation in DRRX by 30. ...Overall, Durect gets a Strong Buy rating from the Street’s analyst consensus, based on 5 unanimously positive reviews. The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock forecast)Durect Stock Chart and Share Price Forecast, Short-Term "DRRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Durect Corp (DRRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024

If you’re looking for stocks under $10 to buy, you can do a lot worse than these highly-rated picks. BBAI BigBear.ai $4.05 APPH AppHarvest $0.95 DRRX Durect 5.18 AUVI Applied UV $1.13 ARDX ...DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$0.62

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Feb 3, 2023 · The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.00 per share and accompanying warrant, and the pre-funded warrants are being sold at a ...

Find the latest DURECT Corporation (DRRX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.Jan 13, 2022 10:00AM EST. A downtrend has been apparent in Durect (DRRX) lately with too much selling pressure. The stock has declined 17.1% over the past four weeks. However, given the fact that ...Find the latest Earnings Report Date for DURECT Corporation Common Stock (DRRX) at Nasdaq.com. Skip ... Read our earnings report guide before you consider the forecast information when ...A. While ratings are subjective and will change, the latest Durect ( DRRX) rating was a downgraded with a price target of $37.00 to $0.00. The current price Durect ( DRRX) is trading at is $0.62 ...Get the latest Pieris Pharmaceuticals Inc (PIRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Dec 1, 2023 · DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an ...

DURECT Corporation stock is higher by 20.39% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives DRRX stock a score of 80 out of a possible 100.. That rank is chiefly influenced by a fundamental score of 95. In addition to the average rating …

DURECT Corp ( DRRX) is up 3.29% today. DRRX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on DRRX! DRRX stock closed at $7.00 and is up $0.23 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.The Takeda Pharmaceutical 52-week low stock price is 13.19, which is 6.8% below the current share price. ... DURECT (DRRX), United States, $0.018B, 0.00. Jaguar ...Last reporting date. November 22, 2023. EPS forecast (this quarter) -$0.86. Annual revenue (last year) $0.00. Annual profit (last year) -$14.6M. Net profit margin.DRRX stock recorded 20/30 (67%) green days with 62.91% price volatility over the last 30 days. Based on our DURECT stock forecast, it's now a bad time to buy DRRX stock because it's trading 19.19% above our forecast. Disclaimer: This is not investment advice. The information provided is for general information purposes only.Based on short-term price targets offered by two analysts, the average price target for Durect comes to $6.75. The forecasts range from a low of $5.00 to a high of $8.50. The average price target ... DRRX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. DURECT CORPORATION (DRRX) Compare. DURECT CORPORATION 3.29 ...DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

View the latest DRRX earnings date, analysts forecasts, earnings history, ... What is DURECT's EPS forecast for next year? DURECT's earnings are expected to grow from ($1.46) per share to ($1.24) per share in the next year. ... Stock Ideas and Recommendations.Read today's DRRX news from trusted media outlets at MarketBeat. Skip to main content. S&P 500 4,514.02. DOW 34,947.28. QQQ 386.04. S&P 500's Whirlwind: Big gains, warning whispers & tactical moves. Trading Experts Call It “The Perfect Tesla Trade” (Ad) ... Durect Shares Slide Premarket on Planned Stock Sale >DRRX marketwatch.com ...Description. _ga. 2 years. The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors. _ga_4G64V72Q46.Analyst Forecast. According to 4 analysts, the average rating for DRRX stock is "Buy." The 12-month stock price forecast is $36.5, which is an increase of 5,883.61% from the latest price.Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week.

Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-Brainer

The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median estimate represents a...DRTT one year forecast. DIRTT Environmental Solutions stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast DRTT stock forecast for 2023 – 2027. Last updated: November 25, 2023. ... Other companies stock forecasts. DRRX Stock Forecast; DRQ Stock Forecast;On average, Wall Street analysts predict that Durect 's share price could reach $34.00 by Aug 10, 2024. The average Durect stock price prediction forecasts a potential upside …According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.For DURECT stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average DURECT stock forecast of $0.99, a high forecast of $1.6, and a low …Nov 27, 2023 · A high-level overview of DURECT Corporation (DRRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Oct 15, 2020 · The Durect stock forecast is 1.3653368157524 USD for 2024 November 26, Tuesday; and 6.830 USD for 2028 November 26, Sunday with technical analysis. Durect (DRRX) stock price prediction is 1.3653368157524 USD.

Oct 2, 2023 · Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-Brainer

Doing some research is necessary before pulling the trigger on any penny stock. Following the recommendations from Wall Street pros can help in the due diligence process. Bearing this in mind, we used the TipRanks database to take a look at two penny stocks getting rave reviews from Oppenheimer analyst Francois Brisebois, with the firm’s …

Stock analysis for Durect Corp (DRRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.View live DURECT Corporation chart to track its stock's price action. Find market predictions, DRRX financials and market news. Search. Products; Community; ... Market closed Market closed. No trades. See on Supercharts. Overview . News Ideas Financials Technicals Forecast . DRRX chart. Today −2.29% 5 days 1.31% 1 month −74.80% 6 …DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update. Durect Earnings Preview. Track Durect Corp (DRRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors. People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.See DURECT Corporation (DRRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.eCommerce double-digit growth in Q3 and share buyback of $18.6M. Raised 2023 Adjusted EBITDA range to $75M - $82M and Non-GAAP Net Income range to $7M - $12M.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for AYRO Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate ...DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis.DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66. DRRX Stock Forecast - Is DRRX a buy or sell? Find out now with a free analysis on DURECT. Should I buy or sell DRRX? DRRX Stock Analysis - [Full Report] DRRX Chart by TradingView. Accessories Stocks Animal Stocks Biopharma Stocks Biopharmaceutical Stocks Clinic Stocks Clinical Stocks

The inventory’s buying and selling value of $2.58 and common value goal of $29.80 mirror the excessive potential of the main drug candidate – and indicate a 1,064% achieve subsequent yr. (be seen DRRX stock forecast)Dec 1, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for DURECT stock is Moderate Buy based on the current 2 hold ratings and 2 buy ratings for DRRX. The average twelve-month price prediction for DURECT is $34.25 with a high price target of $41.00 and a low price target of $27.00. What this means: InvestorsObserver gives Durect Corp (DRRX) an overall rank of 37, which is below average. Durect Corp is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 37 means that 63% of stocks appear more favorable to our system.Based on analysts offering 12 month price targets for DRRX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Instagram:https://instagram. real estate in hong kongwalmart shaq shoesetf for recessionhow many financial advisors in the us GEVO Stock 12 Months Forecast. $6.47. (528.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. The average price target is $6.47 with a high forecast of $14.00 and a low forecast of $2.00. The average price target represents a 528.16% change from the last price of $1.03.DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader. best tax software for independent contractorshow much is a 1921 one dollar coin worth Get the latest TG Therapeutics Inc common stock (TGTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66. silver dollar 1964 value View the latest Durect Corp. (DRRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. DSEY one year forecast. Diversey Holdings stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast DSEY stock forecast for 2023 – 2027. Last updated: November 17, 2023. Are you interested in Diversey Holdings, Ltd. stocks prediction?